You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,118,956


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,118,956
Title:Fusion partners for peptide production
Abstract: The present invention relates to the field of medicine, in particular, to the production of large amounts of a soluble recombinant polypeptide as part of a fusion protein comprising an N-terminal fusion partner linked to the polypeptide of interest.
Inventor(s): Retallack; Diane M. (Poway, CA), Chapman; Adam (San Diego, CA), Bruck; Torben R. (Lakeside, CA), Jin; Hongfan (San Diego, CA)
Assignee: PFENEX INC. (San Diego, CA)
Application Number:14/954,766
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,118,956: A Detailed Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 10,118,956, it is crucial to delve into the scope and claims to understand its implications, validity, and potential applications. This article will provide a comprehensive analysis of the patent landscape, focusing on the key elements of the patent, the significance of its claims, and how it fits into the broader context of patent law and technology.

Patent Overview

United States Patent 10,118,956, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and the tools available for patent analysis.

Claim Structure and Analysis

Claim Types and Scope

Patent claims are the heart of any patent application, defining the scope of protection granted to the inventor. There are typically two types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Eligibility Under § 101

The eligibility of patent claims under 35 U.S.C. § 101 is a critical aspect. Recent updates, such as the 2024 USPTO guidance, emphasize the importance of integrating judicial exceptions into practical applications. Claims must go beyond mere abstract ideas or routine data processing to be eligible. For example, a claim that simply uses a mathematical model without applying it in a specific, practical manner would likely be ineligible. However, if the claim specifies the use of the mathematical model in a real-world application, such as improving speech recognition systems, it would be more likely to meet the criteria for patent eligibility[1].

Practical Applications and Technological Improvements

Real-World Applications

To bolster the argument for patent eligibility, it is essential to highlight the real-world applications of the claimed method or system. For instance, if a claim involves using AI to enhance the accuracy of voice commands in hands-free environments, it must demonstrate how this application provides concrete benefits or solves specific problems in the relevant field. This practical application transforms the abstract idea into patent-eligible subject matter[1].

Technological Improvements

The claimed invention must offer a concrete technological improvement. This involves assessing whether the additional elements in the claim impose meaningful limits on the judicial exception, thereby transforming the claim into patent-eligible subject matter. For example, if a claim specifies the use of separated audio components in a speech recognition system to improve accuracy, it adds a level of practical utility that is not present in a claim that merely manipulates data without a specific application[1].

Patent Landscape and Analytics

Patent Claims Research Dataset

The USPTO provides tools like the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in analyzing the scope and trends of patent claims, including newly-developed measures of patent scope[3].

Claim Coverage Matrix

Using tools like a Claim Coverage Matrix, companies can track patents by claims and scope concepts. This involves categorizing patents not only by claims but also by overarching scope concepts that link claims on similar patents. This method helps in identifying gaps or opportunities in the patent landscape and can be particularly useful in managing a large portfolio of patents[5].

Case Law and Judicial Precedents

Recent Court Decisions

Recent court decisions, such as the case of Mobile Acuity Ltd. v. Blippar Ltd., highlight the challenges in determining patent eligibility under § 101. In this case, the district court found that the claims were directed to abstract ideas and were therefore invalid. This underscores the importance of ensuring that claims are specific, practical, and offer tangible benefits to avoid similar outcomes[2].

Implications for Innovators and Patent Practitioners

AI-Assisted Inventions

The 2024 USPTO guidance update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. This means that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution. This distinction is crucial for innovators using AI in their development processes[1].

Drafting Claims

Practitioners must draft claims that integrate judicial exceptions into practical applications. This involves specifying how the claimed invention is applied in a way that provides concrete benefits or solves specific problems in the relevant field. By doing so, practitioners can help ensure that the claims are more likely to avoid § 101 rejections[1].

Key Takeaways

  • Practical Applications: Claims must specify real-world applications to be eligible.
  • Technological Improvements: Claims must offer concrete technological improvements.
  • AI-Assisted Inventions: AI’s role as a tool does not exclude inventions from eligibility if there is significant human contribution.
  • Claim Eligibility: Claims must integrate judicial exceptions into practical applications to avoid § 101 rejections.
  • Patent Analytics: Tools like the Claim Coverage Matrix and Patent Claims Research Dataset are essential for managing and analyzing patent portfolios.

FAQs

Q: What is the significance of integrating judicial exceptions into practical applications in patent claims? A: Integrating judicial exceptions into practical applications is crucial for ensuring that patent claims are eligible under § 101. This involves specifying how the claimed invention is applied in a way that provides concrete benefits or solves specific problems in the relevant field.

Q: How does the use of AI impact the patent eligibility of an invention? A: The use of AI in the development of an invention does not impact its subject matter eligibility. However, the claimed invention itself must meet the criteria for patent eligibility, including offering significant human contribution and practical applications.

Q: What tools are available for analyzing the scope and claims of patents? A: Tools such as the Patent Claims Research Dataset and Claim Coverage Matrix are available for analyzing the scope and claims of patents. These tools help in categorizing patents by claims and scope concepts, identifying gaps or opportunities, and managing large patent portfolios.

Q: How do recent court decisions influence the drafting of patent claims? A: Recent court decisions, such as Mobile Acuity Ltd. v. Blippar Ltd., emphasize the need for claims to be specific, practical, and offer tangible benefits to avoid being deemed invalid under § 101. This influences practitioners to draft claims that clearly integrate judicial exceptions into practical applications.

Q: What is the role of patent analytics in managing a patent portfolio? A: Patent analytics, using tools like the Claim Coverage Matrix, helps companies track patents by claims and scope concepts, identify gaps or opportunities, and determine the value of their patent claims. This is essential for managing a large portfolio of patents and making informed decisions about future development and protection.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. MOBILE ACUITY LTD. v. BLIPPAR LTD. - CAFC
  3. Patent Claims Research Dataset - USPTO
  4. U.S. Patent and Trademark Office (USPTO) - USA.gov
  5. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.

More… ↓

⤷  Subscribe

Details for Patent 10,118,956

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 June 07, 2000 10,118,956 2034-12-01
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 January 19, 2001 10,118,956 2034-12-01
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 April 23, 2004 10,118,956 2034-12-01
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 October 31, 2013 10,118,956 2034-12-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.